Mitogen-activated protein kinases mediate upregulation of hypothalamic angiotensin II type 1 receptors in heart failure rats

Hypertension

Volumn 52, Issue 4, 2008, Pages 679-686

  Wei, Shun Guang ^a   Yu, Yang ^a   Zhang, Zhi Hua ^a   Weiss, Robert M ^a,b   Felder, Robert B ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ang II; AT1 receptor; Forebrain; Heart failure; MAPK

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSIN 1 RECEPTOR; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P42; PROTEIN P44; STRESS ACTIVATED PROTEIN KINASE; ANGIOTENSIN RECEPTOR ANTAGONIST; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HEART FAILURE; HYPOTHALAMUS; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE MODEL; GENETICS; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; UPREGULATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; HEART FAILURE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; LOSARTAN; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER; UP-REGULATION;

EID: 54749117072     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.113639     Document Type: Article

References (39)

1. Felder RB, Francis J, Zhang ZH, Wei SG, Weiss RM, Johnson AK. Heart failure and the brain: new perspectives. Am J Physiol Regul Integr Comp Physiol. 2003;284:R259-R276.
2. Zhang W, Huang BS, Leenen FH. Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am J Physiol Heart Circ Physiol. 1999;276:H1608-H1615.
3. Unger T, Li J. The role of the renin-angiotensin-aldosterone system in heart failure. J Renin Angiotensin Aldosterone Syst. 2004;5(suppl 1):S7-S10.
4. van Zwieten PA. Compensatory changes of sympathetic tone, the reninangiotensin-aldosterone system, vasopressin, and ANF as potential therapeutic targets in congestive heart failure. Z Kardiol. 1988;77(suppl 5):67-76.
5. Lenkei Z, Palkovits M, Corvol P, Llorens-Cortes C. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol. 1997;18:383-439.
6. Liu D, Gao L, Roy SK, Cornish KG, Zucker IH. Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase. Circ Res. 2006;99:1004-1011.
7. Tan J, Wang H, Leenen FH. Increases in brain and cardiac AT1 receptor and ACE densities after myocardial infarct in rats. Am J Physiol Heart Circ Physiol. 2004;286:H1665-H1671.
8. Moellenhoff E, Blume A, Culman J, Chatterjee B, Herdegen T, Lebrun CJ, Unger T. Effect of repetitive icv injections of Ang II on c-Fos and AT(1)-receptor expression in the rat brain. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1095-R1104.
9. Porter JP. Chronic intracerebroventricular infusion of angiotensin II increases brain AT1 receptor expression in young rats. Brain Res. 1999;112:293-295.
10. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007;292:C82-C97.
11. Gille H, Sharrocks AD, Shaw PE. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature. 1992;358:414-417.
12. Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol. 1996;8:205-215.
13. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991;1072:129-157.
14. Lebrun CJ, Blume A, Herdegen T, Mollenhoff E, Unger T. Complex activation of inducible transcription factors in the brain of normotensive and spontaneously hypertensive rats following central angiotensin II administration. Regul Pept. 1996;66:19-23.
15. Rowland NE, Li BH, Rozelle AK, Fregly MJ, Garcia M, Smith GC. Localization of changes in immediate early genes in brain in relation to hydromineral balance: intravenous angiotensin II. Brain Res Bull. 1994;33:427-436.
16. Murasawa S, Matsubara H, Urakami M, Inada M. Regulatory elements that mediate expression of the gene for the angiotensin II type 1a receptor for the rat. J Biol Chem. 1993;268:26996-27003.
17. Am Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol. 2002;283:R281-R283.
18. Stocker SD, Cunningham JT, Toney GM. Water deprivation increases Fos immunoreactivity in PVN autonomic neurons with projections to the spinal cord and rostral ventrolateral medulla. Am J Physiol Regul Integr Comp Physiol. 2004;287:R1172-R1183.
19. Zucker IH. Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension. 2006;48:1005-1011.
20. Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell. 1988;54:541-552.
21. Wei SG, Yu Y, Zhang ZH, Weiss RM, Felder RB. Circulating angiotensin II upregulates brain angiotensin type I receptors in normal and heart failure rats, (abstract) FASEB J. 2007;21:A1266.
22. Wei SG, Yu Y, Zhang ZH, Weiss RM, Felder RB. Angiotensin II-triggered p44/42 mitogen-activated protein kinase mediates sympathetic excitation in heart failure rats. Hypertension. 2008;52:342-350.
23. Leenen FH, Skarda V, Yuan B, White R. Changes in cardiac Ang II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors. Am J Physiol Heart Circ Physiol. 1999;276:H317-H325.
24. Correa FM, Plunkett LM, Saavedra JM. Quantitative distribution of angiotensin-converting enzyme (kininase II) in discrete areas of the rat brain by autoradiography with computerized microdensitometry. Brain Res. 1986;375:259-266.
25. Lind RW, Swanson LW, Ganten D. Angiotensin II immunoreactive pathways in the central nervous system of the rat: evidence for a projection from the subfornical organ to the paraventricular nucleus of the hypothalamus. Clin Exp Hypertens A. 1984;6:1915-1920.
26. Wright JW, Roberts KA, Stubley LA, Hanesworth JM, Harding JW. Hypothalamic angiotensin release in response to AII or glutamic acid stimulation of the SFO in rats. Brain Res Bull. 1993;31:649-654.
27. Oldfield BJ, Davern PJ, Giles ME, Allen AM, Badoer E, McKinley MJ. Efferent neural projections of angiotensin receptor (AT1) expressing neurones in the hypothalamic paraventricular nucleus of the rat. J Neuroendocrinol. 2001;13:139-146.
28. Zhu GQ, Gao L, Patel KP, Zucker IH, Wang W. Ang II in the paraventricular nucleus potentiates the cardiac sympathetic afferent reflex in rats with heart failure. J Appl Physiol. 2004;97:1746-1754.
29. Pyner S, Coote JH. Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord. Neuroscience. 2000;100:549-556.
30. Francis J, Wei SG, Weiss RM, Felder RB. Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure. Am J Physiol Heart Circ Physiol. 2004;287:H2138-H2146.
31. Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K, Felder RB. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol. 2001;281:H2241-H2251.
32. Lal A, Veinot JP, Ganten D, Leenen FH. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen. J Mol Cell Cardiol. 2005;39:521-529.
33. Huang BS, Leenen FH. Blockade of brain mineralocorticoid receptors or Na+ channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI. Am J Physiol Heart Circ Physiol. 2005;288:H2491-H2497.
34. Zucker IH, Gao L. The regulation of sympathetic nerve activity by angiotensin II involves reactive oxygen species and MAPK. Circ Res. 2005;97:737-739.
35. Mazak I, Fiebeler A, Muller DN, Park JK, Shagdarsuren E, Lindschau C. Dechend R, Viedt C, Pilz B, Haller H, Luft FC. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation. 2004;109:2792-2800.
36. Kida Y, Kobayashi M, Suzuki T, Takeshita A, Okamatsu Y, Hanazawa S, Yasui T, Hasegawa K. Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kappaB in human gingival fibroblasts. Cytokine. 2005;29:159-168.
37. Kreydiyyeh SI, Al-Sadi R. The signal transduction pathway that mediates the effect of interleukin-1 beta on the Na+-K+-ATPase in LLC-PK1 cells. Pflugers Arch. 2004;448:231-238.
38. Yu Y, Wei SG, Zhang ZH, Gomez-Sanchez E, Weiss RM, Felder RB. Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure? Hypertension. 2008;51:727-733.
39. Zhang ZH, Yu Y, Kang YM, Wei SG, Felder RB. Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats. Am J Physiol Heart Circ Physiol. 2008;294:H1067-H1074.